Important Information for agilon Health, Inc. Investors: Class Action Lawsuit Notification

Notice to Shareholders of agilon Health, Inc.

Overview

On February 12, 2026, The Gross Law Firm announced a critical notice for shareholders of agilon health, inc. (NYSE: AGL). This communication is especially directed at those who purchased shares of AGL during a specified class period that spans from February 26, 2025, to August 4, 2025. Investors are encouraged to consider this potential class action lawsuit that may offer them recovery options based on claims of misleading statements from the company.

Key Allegations

The lawsuit revolves around several key allegations against the executives at agilon Health. The complaint highlights that during the class period, the defendants made materially false or deceptive statements and failed to disclose vital information regarding the company’s financial health and strategic forecasts. The allegations include:
1. Reckless guidance for the year 2025, which was anticipated to be unrealistic given the known challenges in the industry.
2. An overstated financial benefit resulting from strategic actions taken by agilon to mitigate risks.
3. Deceptive statements regarding agilon's business operations and overall prospects, suggesting that those positive projections lacked a reasonable basis.

Important Deadlines

Shareholders wishing to participate in this class action case must act quickly. The final day to register as a shareholder seeking to be appointed as a lead plaintiff is March 2, 2026. It is essential to register promptly, as delays could potentially hinder your ability to partake in any recovery resulting from this lawsuit.

Interested parties can easily register online via the following link: Register Here.

Next Steps for Investors

Once shareholders register, they will be monitored through a portfolio monitoring software, which will keep them informed about case developments. The Gross Law Firm assures transparency and offers to guide investors through the process at no cost. Their commitment to protecting investors' rights, especially regarding deceit, fraud, and other illegal corporate actions, underscores the firm’s mission.

Why Align with The Gross Law Firm?

Known for its national prominence in class action litigation, The Gross Law Firm stands out as a dedicated advocate for investors. Their focus on promoting accountability among corporations has granted many shareholders the opportunity for justice and recovery of losses caused by misleading corporate conduct. The firm emphasizes its dedication to ethical business practices and seeks to ensure that these principles are upheld within the corporate environment.

Additionally, it's important to note that previous results do not guarantee similar outcomes in this case, but the firm is passionate about applying its resources and expertise towards defending the rights of all investors adversely affected by corporate misdeeds.

For any inquiries or more information, shareholders may directly contact The Gross Law Firm’s New York office at 15 West 38th Street, 12th floor, New York, NY, 10018, or reach out via email at [email protected] or by phone at (646) 453-8903.

Conclusion

In a rapidly changing business landscape, shareholder rights must be preserved and protected. This class action lawsuit provides an avenue for agilon Health, Inc. investors to seek accountability and potential recovery from the repercussions of deceptive business practices. With the deadline approaching, interested shareholders are strongly encouraged to register and stay informed about the progress of their case.